TB CARE I - Indonesia Annual Report Quarter 4 Annex

The program is led by KNCV, a non-governmental organization, in collaboration with various partners, including the World Health Organization (WHO), the Indonesian Ministry of Health, and other international organizations. The program focuses on several key areas, including universal and early access to TB diagnosis and treatment, laboratory strengthening, infection control, and health systems strengthening. In the third quarter of 2013, significant progress was made in these areas. For example, 98% of the universal and early access target was completed, with 123 hospitals in 92 districts receiving technical assistance for PPM implementation. Laboratory strengthening was also a key area of focus, with 99% of the target completed. This included the development of a monitoring system for healthcare facilities and accredited hospitals, as well as the provision of technical assistance to 32 hospitals in six TB CARE I-supported provinces for DOTS performance reviews. Infection control was another area of emphasis, with 100% of the target completed. This included the provision of technical assistance to 123 hospitals in 92 districts for PPM implementation, as well as the conduct of supervision and backstopping visits by PPM STO to PPM TO in provinces. Health systems strengthening was also a key area of focus, with 98% of the target completed. This included the development of a quick reference material for clinicians, as well as the revision and printing of DOTS managerial guidelines books. TB/HIV collaboration was also a key area of focus, with 99% of the target completed. This included advocacy visits to new prisons, as well as the conduct of workshops for new prisons on TB-HIV collaboration. Overall, the TB CARE I program made significant progress in the third quarter of 2013, with 98% of the overall work plan completion. The program's focus on universal and early access, laboratory strengthening, infection control, health systems strengthening, and TB/HIV collaboration has helped to improve TB control and management in Indonesia. The program's success can be attributed to the strong collaboration between KNCV, the Indonesian Ministry of Health, and other international organizations. The program's focus on technical assistance, capacity building, and supervision has helped to strengthen the capacity of healthcare providers and improve the quality of TB services in Indonesia. The TB CARE I program has also contributed to the development of national guidelines and standards for TB control and management in Indonesia. The program's work on the development of a quick reference material for clinicians, as well as the revision and printing of DOTS managerial guidelines books, has helped to improve the quality of TB services and ensure that healthcare providers have access to the latest information and guidelines. In conclusion, the TB CARE I program has made significant progress in improving TB control and management in Indonesia. The program's focus on universal and early access, laboratory strengthening, infection control, health systems strengthening, and TB/HIV collaboration has helped to improve the quality of TB services and reduce the burden of TB in Indonesia.